Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-17

Clinical Trial Update: Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany

View source ↗

Summary

This real-world study updates the effectiveness and durability of the two-drug HIV regimen dolutegravir + lamivudine in untreated and pre-treated patients withi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)
  • Lamivudine (lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2025-08-17